BRIEF published on 07/16/2025 at 08:05, 1 year 3 months ago GeNeuro SA announces the liquidation of its French subsidiary Restructuring Liquidation GeNeuro Subsidiary Neurodegenerative
BRIEF published on 07/16/2025 at 08:05, 1 year 3 months ago GeNeuro SA annonce la liquidation de sa filiale française Liquidation Restructuration GeNeuro Filiale Neurodégénératif
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases GeNeuro SA announces the liquidation of its French subsidiary GeNeuro Innovation SAS, part of the restructuring process. Court appointed liquidator SELARL MJ-Synergie Liquidation Restructuring Process GeNeuro SA GeNeuro Innovation SAS SELARL MJ-Synergie
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 3 months ago Informations privilégiées / Autres communiqués GeNeuro SA annonce la liquidation de sa filiale GeNeuro Innovation SAS. Le Tribunal de Lyon a prononcé la décision le 15 juillet 2025. La société GeNeuro poursuit sa restructuration Biopharmaceutique Restructuration Liquidation Judiciaire GeNeuro Neurodégénératives
BRIEF published on 06/30/2025 at 19:42, 1 year 3 months ago GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting Shareholder Approval Restructuring Extraordinary General Meeting GeNeuro Asset Monetization
BRIEF published on 06/30/2025 at 19:42, 1 year 3 months ago Les actionnaires de GeNeuro approuvent toutes les résolutions lors de l'assemblée générale extraordinaire Assemblée Générale Extraordinaire Restructuration Approbation Des Actionnaires GeNeuro Monétisation Des Actifs
PRESS RELEASE published on 06/30/2025 at 19:37, 1 year 3 months ago Inside Information / Other news releases GeNeuro announces approval of all resolutions proposed at Extraordinary General Meeting with 69.1% share capital representation. Jesús Martin-Garcia named Executive Chairman Shareholders EGM Resolutions GeNeuro Jesús Martin-Garcia
PRESS RELEASE published on 06/30/2025 at 19:37, 1 year 3 months ago Informations privilégiées / Autres communiqués Les actionnaires de GeNeuro approuvent l’ensemble des résolutions proposées à l’Assemblée Générale Extraordinaire du 30 juin 2025. Jesús Martin-Garcia nommé Président Exécutif Assemblée Générale Extraordinaire Resolutions GeNeuro Neurodégénératives Jesús Martin-Garcia
BRIEF published on 06/12/2025 at 22:47, 1 year 4 months ago GeNeuro SA : Redressement judiciaire pour sa filiale française Restructuration Redressement Judiciaire GeNeuro SA Administrateur Judiciaire Filiale Française
BRIEF published on 06/12/2025 at 22:47, 1 year 4 months ago GeNeuro SA: Judicial recovery for its French subsidiary Restructuring GeNeuro SA Judicial Recovery French Subsidiary Judicial Administrator
Published on 10/28/2026 at 02:55, 11 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 16 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 3 hours 26 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 3 hours 41 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 5 hours 36 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/28/2026 at 02:25, 40 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 AGM Chair and Group CEO address
Published on 10/28/2026 at 02:19, 46 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: September 2026 quarter update
Published on 10/27/2026 at 22:40, 4 hours 25 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 4 hours 35 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 6 hours 30 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 18:00, 9 hours 6 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 9 hours 6 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
